Intestinal Microbiota and Pathogenic Bacteria

The term "intestinal microbiota and pathogenic bacteria" encompasses the diverse microbial consortia inhabiting the gut and the complex interactions between commensal flora and enteric pathogens[3][7]. The intestinal microbiota contributes to host nutrient absorption, immune system development, and protects against infection through mechanisms like niche exclusion and competitive metabolism[3][7]. Pathogenic bacteria, meanwhile, can exploit disruptions in the microbiota (e.g., after antibiotic use or inflammation) to establish infection—sometimes utilizing microbiota-derived metabolites to enhance their own virulence[1][2][4]. The balance between microbiota and pathogens plays a crucial role in diseases such as inflammatory bowel disease, gastrointestinal infections, and certain cancers; thus, therapies like antibiotics, probiotics, and fecal microbiota transplantation seek to restore or manipulate these communities to achieve clinical benefit[4][5][7]. However, the term does not refer to a single molecular, receptor, or protein target, and thus cannot be cleanly classified within standard molecular pharmacology frameworks.

Other names

Gut microbiota and pathogensEnteric microbiota and pathogensGut bacterial community and pathogensIntestinal flora and pathogens

Antibiotics: depletion or modulation of microbial communities, direct killing of pathogens. Probiotics: restoration of beneficial microbiota, competition with pathogens, immune modulation. Fecal microbiota transplantation: restoration of healthy microbiota composition and function.